<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.evergreenstatepress.com/article/910150844-novelty-nobility-taps-agc-biologics-to-further-develop-bispecific-drug-candidate</loc>
      <news:news>
        <news:publication>
          <news:name>Evergreen State Press</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T00:00:00+00:00</news:publication_date>
        <news:title>Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cecf4f80-22df-4bbf-b0a7-f50b9acf9495/medium/agc-biologics-and-novelty-nobility-representatives-meet.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.evergreenstatepress.com/article/910150881-agc</loc>
      <news:news>
        <news:publication>
          <news:name>Evergreen State Press</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T00:00:00+00:00</news:publication_date>
        <news:title>ノベルティ・ノビリティ、AGCバイオロジクスと提携し、二重特異性抗体候補薬の開発を推進</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NWUzMzQxMTYtZjcyYS00YjQ4LWE2ODYtY2ZiNWE0YTlmM2MzLTEzMTU5MjMtMjAyNi0wNS0wNC1qYQ==/tiny/AGC-Biologics-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.evergreenstatepress.com/article/910150885-novelty-nobility-agc-biologics</loc>
      <news:news>
        <news:publication>
          <news:name>Evergreen State Press</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T00:00:00+00:00</news:publication_date>
        <news:title>노벨티 노빌리티 (Novelty Nobility), 이중특이성 항체 개발 위해 AGC Biologics와 협력 확대</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NWUzMzQxMTYtZjcyYS00YjQ4LWE2ODYtY2ZiNWE0YTlmM2MzLTEzMTU5MjMtMjAyNi0wNS0wNC1rbw==/tiny/AGC-Biologics-Inc-.png</image:loc>
        </image:image>
    </url>
</urlset>
